Source:http://linkedlifedata.com/resource/pubmed/id/19643373
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-7-31
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1538-4721
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-72
|
pubmed:meshHeading | |
pubmed:articleTitle |
Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
|
pubmed:affiliation |
Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Susan.Davidson@christie.nhs.uk
|
pubmed:publicationType |
Journal Article
|